News Sentiment

GENB sentiment intelligence

Generate Biomedicines, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 13.56 Week of 17 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-5.3% over one week, -6.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Top Generate Biomedicines (GENB) Competitors 2026

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction -5.3% Price reacting lower
Trend fit Trend inactive -6.4% over four weeks
Fair value 0.6% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 34
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
TradingView 4
simplywall.st 4
Quiver Quantitative 3
MarketBeat 2
Stock Titan 2
Motley Fool 2
PR Newswire 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 15
Analyst action 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47